Clinical Trial Results:
A randomized, double-blind, placebo-controlled study to
investigate the safety, tolerability and efficacy of orally
administered QAL964 in patients with active rheumatoid
arthritis on stable doses of methotrexate and with
inadequate response to methotrexate
Summary
|
|
EudraCT number |
2013-003493-27 |
Trial protocol |
HU GR |
Global completion date |
01 Jul 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1 |
This version publication date |
01 Nov 2019
|
First version publication date |
01 Nov 2019
|
Other versions |
v2 |
Summary report(s) |
Termination Letter_CQAL964B2201 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.